Skip to content

Recovery in Hand function following robot-assisted training in stroke patients

Robot-assisted training (RAT) in upper-limb motor and functional recovery in stroke patients- A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036836
Enrollment
44
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

Intervention1: Robotic-assisted therapy and conventional upper-limb therapy: This group of patients will receive robotic-assisted training (RAT) for 30 minutes (with Robotic Machine â??Armeo Springâ??

Sponsors

AIIMS Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Stroke occurred within six months 2.1st episode of stroke 3.Mild or no cognitive deficit [Mini mental Status Score > 21 points] 4. Presence of minimal voluntary active shoulder abduction and flexion and elbow flexion (at least 10-20° active ROM at shoulder abduction and flexion, and 10-20° active elbow flexion) 5.Presence of spasticity in elbow flexors of grade one plus (1+) or more in modified Ashworth scale.

Exclusion criteria

Exclusion criteria: 1.Recurrent stroke 2.Presence of neuropathic pain in affected limb 3.Presence of contractures of affected wrist and fingers 4.Severe spasticity of affected limb (MAS >3) 5.COgnitive dysfunction (MMSE 6.Haemodynamically unstable patients 7.Presence of previous neurological disorder (due to any etiology)

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment scale for upper extremity(FMA-UE)Timepoint: Participants will be followed up at three weeks (3 Weeks) and six weeks (6 Weeks) following the start of therapy.

Secondary

MeasureTime frame
1.The World Health Organization Quality of Life instrument (WHO-QOL BREF) questionnaire 2.Modified Ashworth Scale(MAS) Timepoint: Participants will be followed up at three weeks (3 Weeks) and six weeks (6 Weeks) following the start of therapy.

Countries

India

Contacts

Public ContactSouvik Bhattacharjee

All India Institute Of Medical Sciences, Bhubaneswar.

apurvaa23@gmail.com9438884211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026